epilepsy
epilepsy
epilepsy
• Brain tumors, central nervous system (CNS) infections, and neurodegenerative diseases
are other common causes.
• Seizures attack could be resulted from various causes, like electrolyte disturbance,
hypoxia, toxicity, or some drugs
Pathophysiology
• Groups of neurons fires rapidly and
repetitively for seconds to minutes.
• Cortical electrical discharges become
excessively rapid, rhythmic, and
synchronous.
• This phenomenon is presumably related to
an excess of excitatory neurotransmitter
action, a failure of inhibitory
neurotransmitter action, or a combination
of the two.
• In individual patients, it is usually
impossible to identify which
neurochemical factors are responsible.
• The primary excitatory neurotransmitter is glutamate. The result is the opening of
membrane channels allowing sodium or calcium to flow into the neuron,
depolarizing it, and transmitting an excitatory signal.
• 1- Focal:
- with preserved awareness (partial simple)
- with impaired awareness
- with secondary generalization
• 2- Generalized
- abscent seizure
- myoclonic seizure
- tonic –clonic seizure
Signs and symptoms
• Patients who experience seizures may complain of paroxysmal spells of:
• Lapses in memory, periods of altered consciousness
• Warnings or auras consisting of various sensations or automatic, uncontrolled
movements
• Daydreaming
• Jerks, shoulder shrugs, sudden chills of spine
• Falling out
• Associated Symptoms
• Incontinence, usually of urine
• Tongue or cheek biting
• Traumatic injuries, usually associated with falling during a seizure
Diagnosis
• Description of events
• Electroencephalogram (EEG)
• If no risk factors are present, the risk of another seizure is 10% to 15%. However,
if two or more risk factors are present, the risk of another seizure is 100%.
Non-pharmacological treatment
• surgery,
• protein Binding Some ASMs, especially phenytoin and valproate, are highly bound to
plasma proteins. When interpreting a reported concentration for these drugs, it is
important to remember the value represents the total (ie, bound and unbound) con-
centration in the blood.
• Zero-order Pharmacokinetics
Some important notes about treatment
Drug Selection and Seizure Type
The key to selecting effective pharmacotherapy is to base the decision on the seizure
type.
Switching Drugs Changing from one ASM to another can be a complex process. If
the first drug is stopped too abruptly, breakthrough seizures may occur.
Stopping Therapy Epilepsy is generally considered to be a lifelong disorder
requiring ongoing treatment. And these points must be considered:
• Drug interactions:
• Special population:
1- children
• Clinical Symptoms
• of seizures. Doses can be given every 5 minutes until seizure activity stops or toxicities are seen
(e.g., respiratory depression)